316 related articles for article (PubMed ID: 24719498)
61. [Focal segmental glomerulosclerosis--the disease entity or histological type of glomerular injury?].
Wagrowska-Danilewicz M; Danilewicz M
Pol Merkur Lekarski; 2010 Jun; 28(168):482-5. PubMed ID: 20642110
[TBL] [Abstract][Full Text] [Related]
62. Variations of type IV collagen-encoding genes in patients with histological diagnosis of focal segmental glomerulosclerosis.
Demir E; Caliskan Y
Pediatr Nephrol; 2020 Jun; 35(6):927-936. PubMed ID: 31254113
[TBL] [Abstract][Full Text] [Related]
63. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Société de Néphrologie.
Meyrier A; Noël LH; Auriche P; Callard P
Kidney Int; 1994 May; 45(5):1446-56. PubMed ID: 8072258
[TBL] [Abstract][Full Text] [Related]
64. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
[TBL] [Abstract][Full Text] [Related]
65. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
[TBL] [Abstract][Full Text] [Related]
66. The direction and role of phenotypic transition between podocytes and parietal epithelial cells in focal segmental glomerulosclerosis.
Sakamoto K; Ueno T; Kobayashi N; Hara S; Takashima Y; Pastan I; Matsusaka T; Nagata M
Am J Physiol Renal Physiol; 2014 Jan; 306(1):F98-F104. PubMed ID: 24154691
[TBL] [Abstract][Full Text] [Related]
67. Focal segmental glomerulosclerosis: a morphologic diagnosis in evolution.
Thomas DB
Arch Pathol Lab Med; 2009 Feb; 133(2):217-23. PubMed ID: 19195965
[TBL] [Abstract][Full Text] [Related]
68. Glomerular C4d deposition can precede the development of focal segmental glomerulosclerosis.
van de Lest NA; Zandbergen M; Wolterbeek R; Kreutz R; Trouw LA; Dorresteijn EM; Bruijn JA; Bajema IM; Scharpfenecker M; Chua JS
Kidney Int; 2019 Sep; 96(3):738-749. PubMed ID: 31327475
[TBL] [Abstract][Full Text] [Related]
69. Focal Segmental Glomerulosclerosis Associated with Essential Thrombocythemia.
Sugimoto H; Sawa N; Yamagiwa H; Kawada M; Ikuma D; Oba Y; Mizuno H; Sekine A; Yamanouchi M; Hasegawa E; Suwabe T; Nishida A; Kono K; Kinowaki K; Ohashi K; Yamaguchi Y; Ubara Y
Intern Med; 2023 Jun; 62(12):1789-1794. PubMed ID: 36288989
[TBL] [Abstract][Full Text] [Related]
70. Nephrotic syndrome due to focal segmental glomerulosclerosis: long-term outcomes.
Chan JC
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Dec; 32(6):931-7. PubMed ID: 18182706
[TBL] [Abstract][Full Text] [Related]
71. Idiopathic focal segmental glomerulosclerosis: a favourable prognosis in untreated patients?
Deegens JK; Assmann KJ; Steenbergen EJ; Hilbrands LB; Gerlag PG; Jansen JL; Wetzels JF
Neth J Med; 2005 Nov; 63(10):393-8. PubMed ID: 16301760
[TBL] [Abstract][Full Text] [Related]
72. Podocyte phenotypes as defined by expression and distribution of GLEPP1 in the developing glomerulus and in nephrotic glomeruli from MCD, CNF, and FSGS. A dedifferentiation hypothesis for the nephrotic syndrome.
Sharif K; Goyal M; Kershaw D; Kunkel R; Wiggins R
Exp Nephrol; 1998; 6(3):234-44. PubMed ID: 9639039
[TBL] [Abstract][Full Text] [Related]
73. Review on diagnosis and treatment of focal segmental glomerulosclerosis.
Deegens JK; Steenbergen EJ; Wetzels JF
Neth J Med; 2008 Jan; 66(1):3-12. PubMed ID: 18219061
[TBL] [Abstract][Full Text] [Related]
74. Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study.
Valeri A; Barisoni L; Appel GB; Seigle R; D'Agati V
Kidney Int; 1996 Nov; 50(5):1734-46. PubMed ID: 8914044
[TBL] [Abstract][Full Text] [Related]
75. The parietal epithelial cell is crucially involved in human idiopathic focal segmental glomerulosclerosis.
Dijkman H; Smeets B; van der Laak J; Steenbergen E; Wetzels J
Kidney Int; 2005 Oct; 68(4):1562-72. PubMed ID: 16164633
[TBL] [Abstract][Full Text] [Related]
76. Nephrotic syndrome with acute kidney injury due to focal segmental glomerulosclerosis following long-term treatment with minodronate.
Morinishi T; Nawata A; Konishi R; Ono E; Takaori K; Maeda S
CEN Case Rep; 2022 Feb; 11(1):120-125. PubMed ID: 34455572
[TBL] [Abstract][Full Text] [Related]
77. Expression of Wilms' Tumor 1 Antigen, Vimentin, and Corticotropin-Releasing Factor in the Human Kidney with Focal Segmental Glomerulosclerosis and Effect of Oxidative Stress on These Markers in HEK 293 Cells.
Csurgyók R; Sütő G; Wittmann I; Vas T
Kidney Blood Press Res; 2023; 48(1):56-65. PubMed ID: 36529126
[TBL] [Abstract][Full Text] [Related]
78. Podocyte-associated gene mutation screening in a heterogeneous cohort of patients with sporadic focal segmental glomerulosclerosis.
Laurin LP; Lu M; Mottl AK; Blyth ER; Poulton CJ; Weck KE
Nephrol Dial Transplant; 2014 Nov; 29(11):2062-9. PubMed ID: 24500309
[TBL] [Abstract][Full Text] [Related]
79. Obesity-related glomerulopathy: an emerging epidemic.
Kambham N; Markowitz GS; Valeri AM; Lin J; D'Agati VD
Kidney Int; 2001 Apr; 59(4):1498-509. PubMed ID: 11260414
[TBL] [Abstract][Full Text] [Related]
80. Mechanisms of disease: focal segmental glomerulosclerosis.
Meyrier A
Nat Clin Pract Nephrol; 2005 Nov; 1(1):44-54. PubMed ID: 16932363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
